We use cookies to ensure that we give you the best experience on our website Learn more


Saved research


6 - Admission by cardiorespiratory arrest in an Intensive Care Unit.


and 1 other(s)

0 Saves

Presented at

ERC congress - Resuscitation 2018





Cardiorespiratory arrest (CRP) is a critical event that requires admission to an Intensive Care Unit (ICU) when spontaneous recovery of circulation occurs due to the need for vital support and neurological monitoring. Objectives: Characterization of the patients hospitalized by CRP in an ICU of a district Hospital between January 2013 and December 2017. Methods: Retrospective and transversal evaluation of the hospitalization episodes by PCR in the previously mentioned period. Results: A total of 209 patients were identified, 56.5% male and 43.5% female. Mean age of 72.3 years. Most were previously autonomous, with important comorbidities such as chronic kidney disease and cardio and cerebrovascular diseases. In addition to those assisted in the Emergency room, patients with pre-hospital spontaneous circulation recovery (ROSC) were also included, with direct admission to the ICU. The most common presentation rate was non-defibrillation. With a mean resuscitation time of 13 minutes and an initial Glasgow score of 3 to 5. The three main causes of CRP were global respiratory insufficiency, airway obstruction and acute myocardial infarction. At admission to the ICU, the mean severity indexes corresponded to SAPS II of 63.2 and APACHE II of 34 (mortality of 70.97% and 74.76%, respectively). The death rate from this event was 66.03%. CONCLUSIONS: Mortality due to CRP is high, with predominance of females in our population, highlighting important and high-prevalence comorbidities, absence of early basic life support (BLS) and delayed advanced life support (ALS), as a probable cause of non-reversal of the disease although ICU support, with normothermia, mechanical ventilation and neurological monitoring. It is fundamental to implement a social education program by massifying the BLS and faster access to the ALS, strengthening the links of the survival chain, allowing a greater chance of survival with quality.


No datasets are available for this submission.


No license information is available for this submission.



Follow us

© Copyright 2019 Morressier GmbH. All rights reserved.

© Copyright 2019 Morressier GmbH.
All rights reserved.